16Dec 2021
Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction

Bivalirudin Versus Heparin Monotherapy in ST-Segment–Elevation Myocardial Infarction

Bivalirudin was not superior to unfractionated heparin in patients with myocardial infarction (MI) treated with percutaneous coronary intervention and no planned use of GPI (glycoprotein IIb/IIIa inhibitors) in contemporary clinical practice of radial access and potent P2Y12-inhibitors in the VALIDATE-SWEDEHEART randomized clinical trial (Bivalirudin Versus Heparin in STEMI and NSTEMI Patients on Modern Antiplatelet Therapy–Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies Registry)...

  • #family health

Like

Save

Share